sb 203580 has been researched along with rg 14620 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (rg 14620) | Trials (rg 14620) | Recent Studies (post-2010) (rg 14620) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 8 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, XM; Shen, HM; Wang, XY; Xiao, L; Xu, CF; Yang, YB | 1 |
1 other study(ies) available for sb 203580 and rg 14620
Article | Year |
---|---|
[Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endometrial Neoplasms; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Imidazoles; PTEN Phosphohydrolase; Pyridines; Signal Transduction; Sirolimus; Transfection; Tyrphostins | 2009 |